908 Devices, Inc. (MASS)
7.955
-0.10
(-1.30%)
USD |
NASDAQ |
May 07, 13:37
908 Devices SG&A Expense (TTM) : 28.29M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Repligen Corp. | 219.25M |
| Abbott Laboratories | 13.01B |
| Accuray, Inc. | 88.55M |
| Alphatec Holdings, Inc. | 371.51M |
| Plus Therapeutics, Inc. | 12.13M |